ArticleInternational journal of molecular sciences2025
A Comparative Analysis of Absorbance- and Fluorescence-Based 1,3-Diphenylisobenzofuran Assay and Its Application for Evaluating Type II Photosensitization of Flavin Derivatives.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Singlet oxygen is a type of reactive oxygen species that is typically generated via type II photosensitization reactions. Since 1,3-diphenylisobenzofuran (DPBF), a commonly used chromogenic probe, exhibits peak absorbance at 410 nm for singlet oxygen detection, it severely interferes with blue light irradiation and compounds that absorb in this wavelength region. This study investigated developing and validating a fluorescence-based method using DPBF to quantitatively analyze the type II photosensitizing property of riboflavin (RF) and its heterocyclic flavin derivatives. DPBF fluorescence-based analysis provided more sensitive and practical results than traditional colorimetric methods. It effectively overcomes spectral interference from colored photosensitizers, such as RF and its derivatives, under blue light irradiation (λ peak 447 nm). This method permitted more effective measurement of their activity without interference from their intrinsic color and maintained high linearity and low variation across different sample concentrations, even with short irradiation times. The type II photosensitizing potency of the tested compounds under blue light was consistently ranked as follows: RF > flavin mononucleotide > flavin adenine dinucleotide > lumiflavin > lumichrome. The results suggest that the DPBF fluorescence-based assay is a more effective approach than colorimetric analysis, making it a practical and reproducible tool for assessing the type II photosensitizing properties of diverse compounds. This study also provides a refinement of an existing probe-based assay for relative comparisons under visible light conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.